<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fox Lake Towing and Recovery &#187; obesity</title>
	<atom:link href="http://foxrecovery.com/tag/obesity/feed/" rel="self" type="application/rss+xml" />
	<link>http://foxrecovery.com</link>
	<description>Any Time - Any Where!</description>
	<lastBuildDate>Sat, 26 Mar 2011 01:40:11 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>The Top 10 Health Care Stories of 2010</title>
		<link>http://foxrecovery.com/2010/12/the-top-10-health-care-stories-of-2010/</link>
		<comments>http://foxrecovery.com/2010/12/the-top-10-health-care-stories-of-2010/#comments</comments>
		<pubDate>Wed, 29 Dec 2010 12:30:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[@aoloriginal]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[ACL]]></category>
		<category><![CDATA[ACTC]]></category>
		<category><![CDATA[affordable care act]]></category>
		<category><![CDATA[AGN]]></category>
		<category><![CDATA[aids]]></category>
		<category><![CDATA[aids prevention]]></category>
		<category><![CDATA[aids research]]></category>
		<category><![CDATA[aids treatments]]></category>
		<category><![CDATA[ARNA]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[benadryl recall 2010]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech layoffs]]></category>
		<category><![CDATA[cheese recall]]></category>
		<category><![CDATA[childrens medicine]]></category>
		<category><![CDATA[childrens medicine recall]]></category>
		<category><![CDATA[diet drugs]]></category>
		<category><![CDATA[egg recall]]></category>
		<category><![CDATA[egg recall 2010]]></category>
		<category><![CDATA[employer benefits]]></category>
		<category><![CDATA[employer healthcare]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[FDA Food Safety Modernization Act]]></category>
		<category><![CDATA[fda warning]]></category>
		<category><![CDATA[food safety]]></category>
		<category><![CDATA[food safety bill]]></category>
		<category><![CDATA[GENZ]]></category>
		<category><![CDATA[Genzyme Corporation]]></category>
		<category><![CDATA[GERN]]></category>
		<category><![CDATA[GILD]]></category>
		<category><![CDATA[glaxosmithkline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[health benefits]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[health care reform]]></category>
		<category><![CDATA[health insurance]]></category>
		<category><![CDATA[health insurance costs]]></category>
		<category><![CDATA[Health insurance premiums]]></category>
		<category><![CDATA[health insurance reform]]></category>
		<category><![CDATA[HIV AIDS]]></category>
		<category><![CDATA[hiv prevention]]></category>
		<category><![CDATA[HIV treatment]]></category>
		<category><![CDATA[j j]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[JNJ, GILD, OREX, ARNA, VVUS, AZN, PFE, MRK, NVS, ACL, SNY, GENZ, AGN, ABT, GSK, GERN, ACTC, RHHBY]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[johnson and johnson]]></category>
		<category><![CDATA[Medicaid]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[motrin recall]]></category>
		<category><![CDATA[MRK]]></category>
		<category><![CDATA[Mylanta]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[OREX]]></category>
		<category><![CDATA[pfe]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharma layoffs]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[RHHBY]]></category>
		<category><![CDATA[rolaids recall 2010]]></category>
		<category><![CDATA[sanofi-aventis]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[VVUS]]></category>
		<category><![CDATA[weight loss]]></category>

		<guid isPermaLink="false">http://19776353</guid>
		<description><![CDATA[
                       Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting -- if not always positive -- year. Here's our rundown of the...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/12/the-top-10-health-care-stories-of-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year</title>
		<link>http://foxrecovery.com/2010/10/vivus-shares-rally-on-hopes-obesity-drug-will-gain-approval-next-year/</link>
		<comments>http://foxrecovery.com/2010/10/vivus-shares-rally-on-hopes-obesity-drug-will-gain-approval-next-year/#comments</comments>
		<pubDate>Fri, 29 Oct 2010 15:10:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[ARNA]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[diet drugs]]></category>
		<category><![CDATA[diet pills]]></category>
		<category><![CDATA[drug approval]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[obesity in America]]></category>
		<category><![CDATA[obesity medication]]></category>
		<category><![CDATA[obesity pills]]></category>
		<category><![CDATA[obesity treatment]]></category>
		<category><![CDATA[OREX]]></category>
		<category><![CDATA[Orexigen]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical stocks]]></category>
		<category><![CDATA[Stocks in the News]]></category>
		<category><![CDATA[Vivus]]></category>
		<category><![CDATA[VVUS]]></category>
		<category><![CDATA[VVUS, ABT, ARNA, OREX]]></category>

		<guid isPermaLink="false">http://19694858</guid>
		<description><![CDATA[
                       Vivus shares are soaring this morning, even though the U.S. Food and Drug Administration rejected the drugmaker's obesity drug Qnexa yesterday. Investors are hoping that the FDA's rejection, which includes a request for more sa...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/10/vivus-shares-rally-on-hopes-obesity-drug-will-gain-approval-next-year/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Former McDonald&#8217;s Manager Not Lovin&#8217; His Weight Gain</title>
		<link>http://foxrecovery.com/2010/10/former-mcdonalds-manager-not-lovin-his-weight-gain/</link>
		<comments>http://foxrecovery.com/2010/10/former-mcdonalds-manager-not-lovin-his-weight-gain/#comments</comments>
		<pubDate>Thu, 28 Oct 2010 23:00:00 +0000</pubDate>
		<dc:creator>Danny King</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[employee]]></category>
		<category><![CDATA[employee health]]></category>
		<category><![CDATA[employee safety]]></category>
		<category><![CDATA[employees]]></category>
		<category><![CDATA[fast food]]></category>
		<category><![CDATA[food and beverage]]></category>
		<category><![CDATA[franchise]]></category>
		<category><![CDATA[franchises]]></category>
		<category><![CDATA[labor]]></category>
		<category><![CDATA[MCD]]></category>
		<category><![CDATA[mcdonald]]></category>
		<category><![CDATA[mcdonalds]]></category>
		<category><![CDATA[McDonalds Corp]]></category>
		<category><![CDATA[McDonalds Corporation]]></category>
		<category><![CDATA[mcdonalds lawsuit]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[restaurant]]></category>
		<category><![CDATA[restaurants]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[weight gain]]></category>

		<guid isPermaLink="false">http://19693988</guid>
		<description><![CDATA[
                       McDonald's has lost a $17,500 lawsuit from a former franchise manager in Brazil, who says he put on 65 pounds during his 12 years of working for the chain. The former employee blames the company's policy of mandatory food sampl...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/10/former-mcdonalds-manager-not-lovin-his-weight-gain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abbott Pulls Weight Loss Drug Meridia from the Market</title>
		<link>http://foxrecovery.com/2010/10/abbott-pulls-weight-loss-drug-meridia-from-the-market/</link>
		<comments>http://foxrecovery.com/2010/10/abbott-pulls-weight-loss-drug-meridia-from-the-market/#comments</comments>
		<pubDate>Fri, 08 Oct 2010 20:14:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abbott pulls meridia]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[best weight loss]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[diet drug]]></category>
		<category><![CDATA[diet pills]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[food and drug administration]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[heart attack]]></category>
		<category><![CDATA[lose weight]]></category>
		<category><![CDATA[Meridia]]></category>
		<category><![CDATA[meridia health risks]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[obesity drug]]></category>
		<category><![CDATA[overweight]]></category>
		<category><![CDATA[scout]]></category>
		<category><![CDATA[sibutramine]]></category>
		<category><![CDATA[Stocks in the News]]></category>
		<category><![CDATA[stroke]]></category>
		<category><![CDATA[weight loss]]></category>
		<category><![CDATA[weight loss drugs]]></category>
		<category><![CDATA[weight loss pills]]></category>

		<guid isPermaLink="false">http://19666902</guid>
		<description><![CDATA[
                       Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia,  (sibutramine) from the U.S. market at the request of the FDA, due to concerns it incr...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/10/abbott-pulls-weight-loss-drug-meridia-from-the-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Americans Lag in Life Expectancy &#8212; Even as Health Care Spending Soars</title>
		<link>http://foxrecovery.com/2010/10/why-americans-lag-in-life-expectancy-even-as-health-care-spending-soars/</link>
		<comments>http://foxrecovery.com/2010/10/why-americans-lag-in-life-expectancy-even-as-health-care-spending-soars/#comments</comments>
		<pubDate>Thu, 07 Oct 2010 16:50:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[@aoloriginal]]></category>
		<category><![CDATA[@social]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[health care costs]]></category>
		<category><![CDATA[health reform]]></category>
		<category><![CDATA[homicide]]></category>
		<category><![CDATA[life expectancy]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[Survival Rate]]></category>

		<guid isPermaLink="false">http://19664542</guid>
		<description><![CDATA[
                       A new study from Columbia University finds that the reasons America is lagging other countries aren't the commonly cited obesity, smoking, traffic fatalities and homicide. Rather, the problem has been poor health care, or rathe...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/10/why-americans-lag-in-life-expectancy-even-as-health-care-spending-soars/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New York Wants to Ban Sugary Drinks from Food Stamp Purchases</title>
		<link>http://foxrecovery.com/2010/10/new-york-wants-to-ban-sugary-drinks-from-food-stamp-purchases/</link>
		<comments>http://foxrecovery.com/2010/10/new-york-wants-to-ban-sugary-drinks-from-food-stamp-purchases/#comments</comments>
		<pubDate>Thu, 07 Oct 2010 10:49:00 +0000</pubDate>
		<dc:creator>Hugh Collins</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[food stamps]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[new york]]></category>
		<category><![CDATA[new york city]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[obesity prevention]]></category>
		<category><![CDATA[retail]]></category>
		<category><![CDATA[soda]]></category>
		<category><![CDATA[SodaTax]]></category>
		<category><![CDATA[Taxes]]></category>

		<guid isPermaLink="false">http://19664545</guid>
		<description><![CDATA[Mayor Michael Bloomberg sought permission from the federal government to bar New York City's 1.7 million food stamp recipients from using them to buy sugary drinks such as sodas. <br />
<br />
Bloomberg, a staunch advocate of anti-obesity measures, sent the request to the United States Department of Agriculture, <a href="http://www.nytimes.com/2010/10/07/nyregion/07stamps.html?hp">The New York Times reported. <br />
</a><br />
<div><span>Sponsored Links</span> </div>
The mayor asked for a two-year ban to examine whether...<p><a rel="bookmark" href="http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/">Continue reading <em>New York Wants to Ban Sugary Drinks from Food Stamp Purchases</em></a>
     </p>

     <p><a href="http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/">New York Wants to Ban Sugary Drinks from Food Stamp Purchases</a> originally appeared on <a href="http://www.dailyfinance.com">DailyFinance</a> on Thu, 07 Oct 2010 06:49:00.</p>
     Filed Under:  <a href="http://www.dailyfinance.com/category/health-care/" rel="tag">Health Care</a>, <a href="http://www.dailyfinance.com/category/taxes/" rel="tag">Taxes</a>, <a href="http://www.dailyfinance.com/category/retail/" rel="tag">Retail</a><div><p><a href="http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/" rel="bookmark"></a></p><br />
<div><a href="http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/" rel="bookmark" title="Permanent link to this entry">Permalink</a> &#124; <a href="http://twitter.com/home?source=DailyFinance.com&#38;status=From%20@daily_finance:%20http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/">Tweet this!</a> &#124; <a href="http://www.dailyfinance.com/story/taxes/new-york-wants-to-stop-food-stamps-being-used-to-buy-soda/19664545/#Comments" title="View reader comments on this entry">Comments</a></div></div>]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/10/new-york-wants-to-ban-sugary-drinks-from-food-stamp-purchases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study: Obesity Is Bad for Your Bottom Line</title>
		<link>http://foxrecovery.com/2010/09/new-study-obesity-is-bad-for-your-bottom-line/</link>
		<comments>http://foxrecovery.com/2010/09/new-study-obesity-is-bad-for-your-bottom-line/#comments</comments>
		<pubDate>Wed, 22 Sep 2010 00:33:00 +0000</pubDate>
		<dc:creator>Matthew Scott</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[@aoloriginal]]></category>
		<category><![CDATA[fat]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[obesity]]></category>

		<guid isPermaLink="false">http://19643116</guid>
		<description><![CDATA[
                       Obesity is expensive. Each year, obese American men pay an additional $2,646 to carry their extra weight, while obese women pay $4,879. That's the surprising result of a new study on the individual cost of obesity.
           ...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/09/new-study-obesity-is-bad-for-your-bottom-line/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Panel Votes Against Arena&#8217;s Diet Drug</title>
		<link>http://foxrecovery.com/2010/09/fda-panel-votes-against-arenas-diet-drug/</link>
		<comments>http://foxrecovery.com/2010/09/fda-panel-votes-against-arenas-diet-drug/#comments</comments>
		<pubDate>Thu, 16 Sep 2010 23:00:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Arena]]></category>
		<category><![CDATA[ARNA]]></category>
		<category><![CDATA[ARNA, ABT, VVUS]]></category>
		<category><![CDATA[diet drug]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Lorcaserin]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[obesity drug]]></category>
		<category><![CDATA[Stocks in the News]]></category>
		<category><![CDATA[VVUS]]></category>

		<guid isPermaLink="false">http://19637158</guid>
		<description><![CDATA[
                       Another diet drug, Arena Pharmaceuticals's Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
                Continue reading FDA Panel Votes Against Aren...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/09/fda-panel-votes-against-arenas-diet-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA to Review Arena&#8217;s Diet Drug, Alkermes&#8217; Painkiller Addiction Med</title>
		<link>http://foxrecovery.com/2010/09/fda-to-review-arenas-diet-drug-alkermes-painkiller-addiction-med/</link>
		<comments>http://foxrecovery.com/2010/09/fda-to-review-arenas-diet-drug-alkermes-painkiller-addiction-med/#comments</comments>
		<pubDate>Thu, 16 Sep 2010 11:45:00 +0000</pubDate>
		<dc:creator>Melly Alazraki</dc:creator>
				<category><![CDATA[Towing]]></category>
		<category><![CDATA[@aoloriginal]]></category>
		<category><![CDATA[Abbott]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[ALKS]]></category>
		<category><![CDATA[Arena]]></category>
		<category><![CDATA[ARNA]]></category>
		<category><![CDATA[ARNA, ALKS, AZN, VVUS, OREX, ABT, SNY, BMY]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[brilinta]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Meridia]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[OREX]]></category>
		<category><![CDATA[Orexigen]]></category>
		<category><![CDATA[painkillers]]></category>
		<category><![CDATA[pharma stocks]]></category>
		<category><![CDATA[pharmaceutical stocks]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[plavix]]></category>
		<category><![CDATA[Qnexa]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[Vivitrol]]></category>
		<category><![CDATA[Vivus]]></category>
		<category><![CDATA[VVUS]]></category>

		<guid isPermaLink="false">http://19636007</guid>
		<description><![CDATA[
                       It's a busy day at the FDA today as panels meet to discuss two new drugs -- one to help weight loss and the other to combat drug addiction -- and decide whether to approve AstraZeneca's new blood thinner medication.
          ...]]></description>
		<wfw:commentRss>http://foxrecovery.com/2010/09/fda-to-review-arenas-diet-drug-alkermes-painkiller-addiction-med/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

